XML 94 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Segment and Geographical Information (Tables)
 12 Months Ended
Dec. 31, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Business Segment Information
(In millions)201920182017
Revenues
Life Sciences Solutions
$6,856  $6,269  $5,728  
Analytical Instruments
5,522  5,469  4,821  
Specialty Diagnostics
3,718  3,724  3,486  
Laboratory Products and Services
10,599  10,035  7,825  
Eliminations
(1,153) (1,139) (942) 
Consolidated revenues
25,542  24,358  20,918  
Segment Income (a)
Life Sciences Solutions
2,446  2,158  1,894  
Analytical Instruments
1,273  1,247  1,027  
Specialty Diagnostics
930  952  927  
Laboratory Products and Services
1,324  1,258  1,004  
Subtotal reportable segments (a)
5,973  5,615  4,852  
Cost of revenues charges, net
(17) (12) (123) 
Selling, general and administrative charges, net
(62) (29) (78) 
Restructuring and other income (costs), net
413  (50) (97) 
Amortization of acquisition-related intangible assets
(1,713) (1,741) (1,594) 
Consolidated operating income
4,594  3,783  2,960  
Interest income (b)
224  137  81  
Interest expense (b)
(676) (667) (592) 
Other (expense) income, net (b)
(72) 9  (20) 
Income from Continuing Operations Before Income Taxes
$4,070  $3,262  $2,429  
Depreciation
Life Sciences Solutions
$130  $119  $129  
Analytical Instruments
75  73  71  
Specialty Diagnostics
67  76  72  
Laboratory Products and Services
292  258  167  
Consolidated depreciation
$564  $526  $439  
(a)Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs/income, net; and amortization of acquisition-related intangibles.
(b)The company does not allocate interest or other expense/income, net to its segments.
(In millions)201920182017
Total Assets
Life Sciences Solutions
$18,306  $18,774  $19,063  
Analytical Instruments
9,896  9,907  9,960  
Specialty Diagnostics
5,867  6,663  7,095  
Laboratory Products and Services
21,761  19,051  19,181  
Corporate/Other (c)
2,551  1,837  1,370  
Consolidated total assets
$58,381  $56,232  $56,669  
Capital Expenditures
Life Sciences Solutions
$151  $107  $118  
Analytical Instruments
64  85  56  
Specialty Diagnostics
83  103  87  
Laboratory Products and Services
554  374  178  
Corporate/Other
74  89  69  
Consolidated capital expenditures
$926  $758  $508  
(c)Corporate assets consist primarily of cash and cash equivalents and property and equipment at the company's corporate offices.
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Business Segment Information
(In millions)201920182017
Revenues
Life Sciences Solutions
$6,856  $6,269  $5,728  
Analytical Instruments
5,522  5,469  4,821  
Specialty Diagnostics
3,718  3,724  3,486  
Laboratory Products and Services
10,599  10,035  7,825  
Eliminations
(1,153) (1,139) (942) 
Consolidated revenues
25,542  24,358  20,918  
Segment Income (a)
Life Sciences Solutions
2,446  2,158  1,894  
Analytical Instruments
1,273  1,247  1,027  
Specialty Diagnostics
930  952  927  
Laboratory Products and Services
1,324  1,258  1,004  
Subtotal reportable segments (a)
5,973  5,615  4,852  
Cost of revenues charges, net
(17) (12) (123) 
Selling, general and administrative charges, net
(62) (29) (78) 
Restructuring and other income (costs), net
413  (50) (97) 
Amortization of acquisition-related intangible assets
(1,713) (1,741) (1,594) 
Consolidated operating income
4,594  3,783  2,960  
Interest income (b)
224  137  81  
Interest expense (b)
(676) (667) (592) 
Other (expense) income, net (b)
(72) 9  (20) 
Income from Continuing Operations Before Income Taxes
$4,070  $3,262  $2,429  
Depreciation
Life Sciences Solutions
$130  $119  $129  
Analytical Instruments
75  73  71  
Specialty Diagnostics
67  76  72  
Laboratory Products and Services
292  258  167  
Consolidated depreciation
$564  $526  $439  
(a)Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs/income, net; and amortization of acquisition-related intangibles.
(b)The company does not allocate interest or other expense/income, net to its segments.
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
Geographical Information
(In millions)201920182017
Revenues (d)
United States
$12,366  $11,629  $10,129  
China
2,752  2,504  2,060  
Other
10,424  10,225  8,729  
Consolidated revenues
$25,542  $24,358  $20,918  
Long-lived Assets (e)
United States
$3,099  $2,444  $2,349  
Other
2,349  1,721  1,698  
Consolidated long-lived assets
$5,448  $4,165  $4,047  
(d)Revenues are attributed to countries based on customer location.
(e)Includes property, plant and equipment, net, and beginning in 2019, operating lease right-of-use assets.